Meitav Investment House’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.19M Hold
33,400
0.06% 96
2025
Q1
$4.57M Sell
33,400
-69,438
-68% -$9.5M 0.08% 91
2024
Q4
$15.7M Buy
102,838
+85,986
+510% +$13.1M 0.27% 73
2024
Q3
$3.27M Hold
16,852
0.05% 103
2024
Q2
$3.91M Buy
16,852
+12
+0.1% +$2.78K 0.07% 97
2024
Q1
$3.63M Buy
16,840
+40
+0.2% +$8.63K 0.07% 93
2023
Q4
$4.35M Buy
16,800
+8
+0% +$2.07K 0.06% 121
2023
Q3
$4.35M Buy
16,792
+2,667
+19% +$690K 0.07% 127
2023
Q2
$3.99M Hold
14,125
0.06% 139
2023
Q1
$4.33M Buy
14,125
+5,600
+66% +$1.72M 0.07% 147
2022
Q4
$2.36M Hold
8,525
0.04% 176
2022
Q3
$2.25M Sell
8,525
-8,468
-50% -$2.24M 0.04% 184
2022
Q2
$3.47M Buy
16,993
+1,181
+7% +$241K 0.06% 159
2022
Q1
$3.33M Buy
+15,812
New +$3.33M 0.05% 183
2021
Q3
Sell
-815
Closed -$282K 407
2021
Q2
$282K Sell
815
-800
-50% -$277K 0.01% 362
2021
Q1
$449 Sell
1,615
-259
-14% -$72 0.01% 283
2020
Q4
$457K Sell
1,874
-100
-5% -$24.4K 0.02% 284
2020
Q3
$558K Sell
1,974
-200
-9% -$56.5K 0.03% 242
2020
Q2
$572K Buy
2,174
+1,374
+172% +$362K 0.03% 206
2020
Q1
$253K Sell
800
-200
-20% -$63.3K 0.02% 310
2019
Q4
$297K Buy
+1,000
New +$297K 0.02% 326
2019
Q1
Sell
-31,220
Closed -$9.4M 392
2018
Q4
$9.4M Sell
31,220
-46
-0.1% -$13.8K 0.58% 54
2018
Q3
$11.1M Sell
31,266
-6,684
-18% -$2.38M 0.54% 50
2018
Q2
$11M Sell
37,950
-270
-0.7% -$78.4K 0.49% 58
2018
Q1
$10.5M Buy
38,220
+280
+0.7% +$76.7K 0.53% 56
2017
Q4
$12.1M Buy
+37,940
New +$12.1M 0.71% 53